Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy
Blood and Lymphatic Cancer: Targets and Therapy · 2026-03 · Volume 16 · 1-16
DOI: 10.2147/blctt.s571966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2026-03. Verfasst von Jinjing Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, the First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
- Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma, OK, USA.
Zitieren
APA
Zhang, J., Jiang, Q., Liu, T., Li, H., Liang, Y., Lu, X., Pang, H., Li, S., Li, Y., & Zhang, R. (2026). Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy. Blood and Lymphatic Cancer: Targets and Therapy, Volume 16, 1-16. https://doi.org/10.2147/blctt.s571966
Vancouver
Zhang J, Jiang Q, Liu T, Li H, Liang Y, Lu X, et al. Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy. Blood and Lymphatic Cancer: Targets and Therapy. 2026;Volume 16:1-16. doi:10.2147/blctt.s571966
BibTeX
@article{Zhang2026,
author = {Zhang, Jinjing and Jiang, Qiao and Liu, Tong and Li, Hong and Liang, Ying and Lu, Xianglan and Pang, Hui and Li, Shibo and Li, Yan and Zhang, Rui},
title = {Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 16},
pages = {1--16},
doi = {10.2147/blctt.s571966}
}
EUVIMED